Compound Detail
CHEMBL3115681
NARAZACICLIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL3115681 |
| Name | NARAZACICLIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | VADOZMZXXRBXNY-UHFFFAOYSA-N |
19
Targets
26
Activities
1
Assay Types
0
PK Parameters
20
Publications
3
Known Names
2
Indications
Molecular Properties
429.5
MW (Da)
3.27
ALogP
8
HBA
1
HBD
90.1
PSA (Ų)
0.68
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Neoplasms Carcinoma, Endometrioid
Activity Summary
IC50 26 meas. best 8.42
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclin-dependent kinase 4/cyclin D1 CHEMBL1907601 | IC50 | 8.42 | 8.1933 | 3.8 | 3 |
| NUAK family SNF1-like kinase 1 CHEMBL5784 | IC50 | 8.3 | 8.3 | 5.0 | 2 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 8.04 | 8.04 | 9.2 | 1 |
| CDK6/cyclin D1 CHEMBL2111455 | IC50 | 8.01 | 8.01 | 9.8 | 1 |
| Macrophage colony-stimulating factor 1 receptor CHEMBL1844 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Tyrosine-protein kinase Fyn CHEMBL1841 | IC50 | 7.96 | 7.96 | 11.0 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 7.91 | 7.91 | 12.2 | 1 |
| DU-145 CHEMBL613508 | IC50 | 7.6 | 7.6 | 25.0 | 1 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | IC50 | 7.58 | 7.58 | 26.0 | 2 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | IC50 | 7.58 | 7.58 | 26.0 | 2 |
| K562 CHEMBL385 | IC50 | 7.3 | 7.3 | 50.0 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 7.27 | 7.27 | 53.3 | 1 |
| CDK2/Cyclin A2 CHEMBL3038469 | IC50 | 7.26 | 7.03 | 55.0 | 2 |
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 6.93 | 6.93 | 117.0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform CHEMBL3130 | IC50 | 6.84 | 6.84 | 144.0 | 1 |
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 6.57 | 6.57 | 272.0 | 1 |
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | IC50 | 6.42 | 6.42 | 377.0 | 1 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| CDK7/Cyclin H/MNAT1 CHEMBL3038473 | IC50 | 5.22 | 5.22 | 6000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24417566 | 10.1021/jm401073p | NON-PROTEIN TARGET | 17 |
| 24417566 | 10.1021/jm401073p | MDA-MB-231 | 7 |
| 24417566 | 10.1021/jm401073p | MCF7 | 5 |
| 24417566 | 10.1021/jm401073p | Cyclin-dependent kinase 4/cyclin D1 | 4 |
| 24417566 | 10.1021/jm401073p | Mus musculus | 3 |
| 30234987 | 10.1021/acs.jmedchem.8b00049 | HCT-116 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 24417566 | 10.1021/jm401073p | DU-145 | 2 |
| 24417566 | 10.1021/jm401073p | K562 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 24417566 | 10.1021/jm401073p | Jurkat | 1 |
| 24417566 | 10.1021/jm401073p | COLO 205 | 1 |
| 33356242 | 10.1021/acs.jmedchem.0c00533 | Platelet-derived growth factor receptor beta | 1 |
| 24417566 | 10.1021/jm401073p | A549 | 1 |
| 24417566 | 10.1021/jm401073p | BT-474 | 1 |
| 24417566 | 10.1021/jm401073p | Raji | 1 |
| 24417566 | 10.1021/jm401073p | NCI-H417 | 1 |
| 24417566 | 10.1021/jm401073p | Unchecked | 1 |
| 24417566 | 10.1021/jm401073p | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 1 |
| 24417566 | 10.1021/jm401073p | A-431 | 1 |
Data from ChEMBL 36 via Core Engine